#United States #New York #healthcare #TransMedics #organ transplantation

TransMedics to Present at Upcoming Investor Conferences

TransMedics Group, Inc., a cutting-edge medical technology firm focusing on organ transplant solutions, is gearing up for a significant presence at two upcoming investor conferences in September 2026. This event marks an exciting opportunity for the company to engage with potential investors and stakeholders who are eager to learn about the latest advancements in organ transplant therapies.

On September 14, TransMedics management will be in New York for a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The session is scheduled to commence at 3:20 PM EST, providing a platform for discussions surrounding the company's innovative approaches to organ preservation and assessment. This is a crucial moment for TransMedics as they delve into their revolutionary technologies aimed at addressing the need for quality donor organs, especially for patients facing end-stage heart, lung, and liver failures.

The following day, on September 15, the company will continue its engagement at the Baird 2026 Global Healthcare Conference, scheduled for 9:40 AM EST. This dual participation underlines TransMedics' commitment to showcasing their advancements in the medical field and fostering relationships with investors who share a vision for transformative healthcare solutions.

TransMedics is recognized globally for pioneering portable extracorporeal warm perfusion, a technique that enhances the viability of donor organs for transplantation. The company’s headquarters are in Andover, Massachusetts, and it was established to tackle the persistent challenges in organ transplantation, providing better quality organs for those in dire need. The technologies developed by TransMedics not only focus on organ preservation but also aim to improve the assessment methods before transplantation occurs, potentially leading to a higher utilization rate of available organs.

As part of their commitment to transparency and investor communication, TransMedics will offer a live and archived webcast of the fireside chat on their official website. Interested parties can access this via the "Investors" section of the TransMedics website, which will also host the standard investor presentation highlighting the company's recent progress and strategic goals.

About TransMedics Group, Inc.

Founded with a mission to revolutionize organ transplantation, TransMedics stands at the forefront of medical technology which addresses critical gaps in organ availability. The company aims to improve the quality and quantity of organs accessible for transplant, ultimately enhancing patient outcomes in critical healthcare situations.

As the healthcare landscape evolves, investor engagement events like these play a pivotal role in driving forward-thinking solutions and fostering partnerships that can lead to significant advancements in the treatment of life-threatening conditions. TransMedics' participation in these conferences signals not just a strategic business initiative, but also an unwavering dedication to improving global health outcomes through innovative medical technologies.

For more information, potential investors and interested parties are encouraged to reach out to the investor contact, Brian Johnston, at the provided contact number or email address, ensuring everyone has the chance to be involved with this groundbreaking medical initiative.